What are the typical serum protein electrophoresis (SPEP) findings in multiple myeloma?

Serum Protein Electrophoresis Findings in Multiple Myeloma

The typical serum protein electrophoresis (SPEP) finding in multiple myeloma is a monoclonal protein (M-protein) appearing as a sharp, narrow band or spike (M-spike) most commonly in the gamma or beta region of the electrophoresis pattern. 1

Key SPEP Findings in Multiple Myeloma

• M-protein appears as a narrow band in agarose electrophoresis or as a sharp symmetric spike (M-spike) in capillary zone electrophoresis, representing the clonal proliferation of plasma cells 1

• The M-protein is most commonly found in the gamma or beta regions, though rarely it can appear in the alpha-2 region 2

• The M-protein can consist of:

  • Complete immunoglobulin with both heavy and light chains (most common)
  • Light chains only
  • Heavy chains only (rare) 2

• Quantification of the M-protein on SPEP helps track disease progression and response to treatment 1

Distribution of M-Protein Types in Multiple Myeloma

• Most patients (approximately 97%) have detectable serum M-proteins with or without associated urinary M-proteins 1

• About 20% of patients have secretory urinary M-proteins in addition to serum M-proteins 1

• Approximately 3% of patients have neither serum nor urine M-proteins, classified as nonsecretory myeloma 1

Complementary Testing to SPEP

• Serum immunofixation electrophoresis (SIFE) should follow SPEP to specifically identify the type of M-protein (IgG, IgA, IgM, kappa or lambda light chains) 1, 3

• Quantitative immunoglobulin levels (IgG, IgA, IgM) help assess the extent of normal immunoglobulin suppression 1

• Serum free light chain (FLC) assay is essential for:

  • Increasing sensitivity for detecting plasma cell disorders
  • Monitoring nonsecretory or oligosecretory myeloma
  • Documenting stringent complete response according to International Myeloma Working Group criteria 1

• 24-hour urine collection for total protein, urine protein electrophoresis (UPEP), and urine immunofixation electrophoresis (UIFE) should be performed to detect Bence Jones proteinuria 1

Clinical Interpretation and Pitfalls

• An M-spike on SPEP is not specific for multiple myeloma and can be seen in other conditions:

  • Monoclonal gammopathy of undetermined significance (MGUS)
  • Smoldering multiple myeloma
  • Waldenström's macroglobulinemia
  • Solitary plasmacytoma
  • Amyloidosis 3, 4

• Rare cases may show atypical patterns:

  • Double M-bands that can simulate biclonal gammopathy 5
  • M-proteins with unusual mobility (e.g., in alpha-2 region) 2

• The serum FLC assay cannot replace 24-hour UPEP for monitoring patients with measurable urinary M-proteins 1

• For accurate relative quantification in disease monitoring, it's crucial to use the same test method for serial studies 1

Prognostic Implications

• The type and quantity of M-protein detected by SPEP has prognostic significance 1

• Beta-2 microglobulin, often measured alongside SPEP, reflects tumor mass and is a standard measure of tumor burden in multiple myeloma 1, 6

• The combination of beta-2 microglobulin with serum albumin forms the International Staging System (ISS), a powerful prognostic tool 6